Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Post by FactFinder1994on Dec 16, 2015 10:20pm
191 Views
Post# 24390523

News & Media

News & Media Tech1,
While I am very bullish on the opportunity Spectral presents, these last few years have been very quiet on the home front (IMHO).  
You provided a link on the profile of the management team but not a link for the News and Media they have drummed up over the last few years.  Perhaps you could provide the News & Media tab with a summary of items for the last 3 years as presented on the Spectral website?  At the same time perhaps you could provide a summary that details the amount of trading in the USA over the last few years too?  I think in both cases you will be left underwhelmed, as true marketing seems to be weak at best?  
Spectral's sepsis treatment is a story that needs and deserves to be broadcast so that awareness and interest around the world can be generated.  Sepsis is an ongoing crisis and PMX can increase the odds of survival for many.  Let's get it done so patients can start to benefit in great numbers.  
Bullboard Posts